Literature DB >> 25589763

Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model.

Danielle Arbour1, Elsa Tremblay1, Éric Martineau1, Jean-Pierre Julien2, Richard Robitaille3.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a late-onset neuromuscular disease characterized by progressive loss of motor neurons (MNs) preceded by neuromuscular junction (NMJ) denervation. Despite the importance of NMJ denervation in ALS, the mechanisms involved remain unexplored and ill defined. The contribution of glial cells in the disease has been highlighted, including axonal Schwann cell activation that precedes the decline of motor function and the onset of hindlimb paralysis. Because NMJ denervation occurs early in the process and that perisynaptic Schwann cells (PSCs), glial cells at the NMJ, regulate morphological stability, integrity, and repair of the NMJ, one could predict that PSC functions would be altered even before denervation, contributing to NMJ malfunctions. We tested this possibility using a slowly progressive model of ALS (SOD1(G37R) mice). We observed a normal NMJ organization at a presymptomatic stage of ALS (120 d), but PSC detection of endogenous synaptic activity revealed by intracellular Ca(2+) changes was enhanced compared with their wild-type littermates. This inappropriate PSC decoding ability was associated with an increased level of neurotransmitter release and dependent on intrinsic glial properties related to enhanced muscarinic receptor activation. The alteration of PSC muscarinic receptor functions also persists during the preonset stage of the disease and became dependent on MN vulnerability with age. Together, these results suggest that PSC properties are altered in the disease process in a manner that would be detrimental for NMJ repair. The impairments of PSC functions may contribute to NMJ dysfunction and ALS pathogenesis.
Copyright © 2015 the authors 0270-6474/15/350688-19$15.00/0.

Entities:  

Keywords:  SOD1; motor unit properties; muscarinic receptors; perisynaptic Schwann cells; synaptic transmission

Mesh:

Substances:

Year:  2015        PMID: 25589763      PMCID: PMC6605374          DOI: 10.1523/JNEUROSCI.1379-14.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Rebound from Inhibition: Self-Correction against Neurodegeneration?

Authors:  Shobhana Sivaramakrishnan; William P Lynch
Journal:  J Clin Cell Immunol       Date:  2017-03-13

Review 2.  New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.

Authors:  Danielle Arbour; Christine Vande Velde; Richard Robitaille
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

3.  Postnatal Restriction of Activity-Induced Ca2+ Responses to Schwann Cells at the Neuromuscular Junction Are Caused by the Proximo-Distal Loss of Axonal Synaptic Vesicles during Development.

Authors:  Dante J Heredia; Cheng-Yuan Feng; Andrea Agarwal; Kyle Nennecker; Grant W Hennig; Thomas W Gould
Journal:  J Neurosci       Date:  2018-08-24       Impact factor: 6.167

4.  Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis.

Authors:  Emiliano Trias; Mariángeles Kovacs; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Ivan C Moura; Olivier Hermine; Joseph S Beckman; Luis Barbeito
Journal:  Glia       Date:  2019-12-20       Impact factor: 7.452

5.  Modelling FUS Mislocalisation in an In Vitro Model of Innervated Human Muscle.

Authors:  Sonja Prpar Mihevc; Mojca Pavlin; Simona Darovic; Marko Živin; Matej Podbregar; Boris Rogelj; Tomaz Mars
Journal:  J Mol Neurosci       Date:  2017-06-15       Impact factor: 3.444

6.  Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.

Authors:  Elsa Tremblay; Éric Martineau; Richard Robitaille
Journal:  J Neurosci       Date:  2017-08-11       Impact factor: 6.167

Review 7.  Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction.

Authors:  Katherine B Santosa; Alexandra M Keane; Albina Jablonka-Shariff; Bianca Vannucci; Alison K Snyder-Warwick
Journal:  J Neurosci Res       Date:  2018-03-13       Impact factor: 4.164

8.  Diaphragm neuromuscular transmission failure in aged rats.

Authors:  Matthew J Fogarty; Maria A Gonzalez Porras; Carlos B Mantilla; Gary C Sieck
Journal:  J Neurophysiol       Date:  2019-05-01       Impact factor: 2.714

9.  Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS.

Authors:  Emiliano Trias; Peter H King; Ying Si; Yuri Kwon; Valentina Varela; Sofía Ibarburu; Mariángeles Kovacs; Ivan C Moura; Joseph S Beckman; Olivier Hermine; Luis Barbeito
Journal:  JCI Insight       Date:  2018-10-04

Review 10.  Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.

Authors:  Alexander Starr; Rita Sattler
Journal:  Brain Res       Date:  2018-02-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.